Drugs / CT-P42
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04739306 | Jul 2021 → Oct 2022 | diabetic macular edema | Celltrion | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT-P42 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04739306 ↗ |
| Route | Intravitreal | “2mg/0.05 mL by Intravitreal injection” NCT04739306 ↗ |